# Uterotonic Prophylaxis Trial

> **NCT02408965** · PHASE4 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 284 (actual)

## Conditions studied

- Hemorrhage

## Interventions

- **DRUG:** Methergine
- **OTHER:** placebo

## Key facts

- **NCT ID:** NCT02408965
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2019-09-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02408965

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02408965, "Uterotonic Prophylaxis Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02408965. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*